ReviewProstate cancer and prostatic diseases2018

The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation.

Megan McNamara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.